Abstract:Background: Human and mouse natural killer (NK) cells have been shown to develop memory-like function after short-term exposure to the cocktail of IL-12/15/18 or to overnight co-culture with some tumor cell lines. The resulting cells retain enhanced lytic ability for up to 7 days as well as after cryopreservation, and memory-like NK cells (mlNK) have been shown to induce complete remissions in patients with hematological malignancies. No single phenotype has been described for mlNK and the physiological changes induced by the short-term cytokine or tumor-priming which are responsible for these enhanced functions have not been fully characterized. Here, we have generated mlNK by cytokine and tumor-priming to find commonalities to better define the nature of NK cell "memory" in vitro and, for the first time, in vivo. Methods: We initiated mlNK in vitro from healthy donors with cytokines (initiated cytokine-induced memory-like (iCIML)-NK) and by tumor priming (TpNK) overnight and compared them by high-dimensional flow cytometry, proteomic and metabolomic profiling. As a potential mechanism of enhanced cytolytic function, we analyzed the avidity of binding of the mlNK to NK-resistant tumors (z-Movi). We generated TpNK from healthy donors and from cancer patients to determine whether mlNK generated by interaction with a single tumor type could enhance lytic activity. Finally, we used a replication-incompetent tumor cell line (INKmune) to treat patients with myeloid leukaemias to potentiate NK cell function in vivo. Results: Tumor-primed mlNK from healthy donors and patients with cancer showed increased cytotoxicity against multiple tumor cell lines in vitro, analogous to iCIML-NK cells. Multidimensional cytometry identified distinct memory-like profiles of subsets of cells with memory-like characteristics; upregulation of CD57, CD69, CD25 and ICAM1. Proteomic profiling identified 41 proteins restricted to mlNK cells and we identified candidate molecules for the basis of NK memory which can explain how mlNK overcome inhibition by resistant tumors. Finally, of five patients with myelodysplastic syndrome or refractory acute myeloid leukemia treated with INKmune, three responded to treatment with measurable increases in NK lytic function and systemic cytokines. Conclusions: NK cell "memory" is a physiological state associated with resistance to MHC-mediated inhibition, increased metabolic function, mitochondrial fitness and avidity to NK-resistant target cells.

Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance

Stem cell-like memory T cells: A perspective from the dark side

Age Related Human Memory T Cell Subset Evolution and Senescence

Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells

Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy

Maintenance of the human memory T cell repertoire by subset and tissue site

Resident memory (TRM) cells sustain immunity to cancer at sites of frequent metastasis

A novel memory-like Tfh cell subset is precursor to effector Tfh cells in recall immune responses

Characteristics of T-cell receptor repertoire of stem cell-like memory CD4+ T cells

Memory T Cells: Strategies for Optimizing Tumor Immunotherapy

Stem Cell-Like Memory T Cells: the Generation and Application

Research progress of stem memory T cells in tumor therapy

miR-15/16 Restrain Memory T Cell Differentiation, Cell Cycle, and Survival

Tumor‐Associated Monocytes Reprogram CD8+ T Cells into Central Memory‐Like Cells with Potent Antitumor Effects

Innate memory of human Vγ2Vδ2 T cells: Distinct proliferative, migratory and tumorcidal capabilities of γδ memory subsets (52.17)

Identification of human CD4+ T cell populations with distinct antitumor activity

Stem cell-like memory T cells are closely related to follicular helper T lymphocytes

T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values

Type 17 Follicular Helper T (Tfh17) Cells are Superior for Memory Maintenance

Resident memory T cells in antitumor immunity and cancer immunotherapy

T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance.